Tabuniag, Enorencio B.

HRN: 21-73-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/09/2022
08/15/2022
IV
1.5
Q12
Septic Arthritis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Choice  Wrong Choice

Overall appropriateness: No  Wrong Choice

Intervention



Type of Intervention done:

                    

           


Acceptance: